P&S Intelligence

According to P&S Intelligence, the market was valued at $872.0 million in 2018, and it is expected to generate $1,612.2 million revenue by 2024.

The surging prevalence of prostate cancer, mounting geriatric population, and soaring number of government initiatives are expected to drive the U.S. prostate cancer treatment devices market at a CAGR of 5.6% during the forecast period (2020–2030).

The surging prevalence of prostate cancer, mounting geriatric population, and soaring number of government initiatives are expected to drive the U.S. prostate cancer treatment devices market at a CAGR of 5.6% during the forecast period (2020–2030).

The valuation of the market is predicted to grow from $27.8 billion to $144.2 billion from 2019 to 2030. Furthermore, the market is predicted to progress at a CAGR of 15.8% between 2020 and 2030.

The global advanced wound care market is set for lucrative growth in the coming years, as per the estimates of P&S Intelligence, a market research company based in India.

Valued at $9,517.1 million in 2015, the global wound closure products market is projected to demonstrate a CAGR of 6.3% during the forecast period (2016–2022).

Adhesion Barrier Market to Register 7.5% CAGR during 2018–2023

The global biopharmaceuticals market is anticipated to be valued at $278.2 billion by the year 2020. The market is expected to advance at a CAGR of 9.6% during the forecast period.

Dermatology Drugs Market To Generate $55,425.0 Million Revenue by 2030

According to P&S Intelligence, the market reached a revenue of $1.7 billion in 2017, and it is projected to generate $3.0 billion revenue by 2023.